Literature DB >> 17319829

Establishment of cell lines stably expressing HNA-1a, -1b, and -2a antigen with low background reactivity in flow cytometric analysis.

Kazuta Yasui1, Toru Miyazaki, Nobuki Matsuyama, Yoshitaka Kojima, Rika A Furuta, Jun-Ichi Fujisawa, Yoshihiko Tani, Hirotoshi Shibata, Shin-Ichirou Sato, Toshiaki Kato, Hisami Ikeda, Fumiya Hirayama.   

Abstract

BACKGROUND: Antibodies to neutrophil antigens have been implicated in neonatal alloimmune neutropenia, autoimmune neutropenia, and transfusion-related acute lung injury. Most often, neutrophil-specific antibodies are directed toward human neutrophil antigen (HNA)-1 (Fcgamma receptor 3b) and HNA-2a (CD177) in these disorders. STUDY DESIGN AND METHODS: To detect the alloantibodies in the serum samples, a panel of cell lines was established in which the HNA-1a, HNA-1b (polymorphisms of HNA-1), or HNA-2a gene was transduced with a retrovirus vector to confer stable transgene expression in K562 cells that exhibited low background reactivity to human serum samples obtained from healthy donors in flow cytometric analysis.
RESULTS: It was shown that several well-characterized human serum samples containing antibodies against HNA-1a, -1b, and -2a were unambiguously identified by the established panel cell lines and observed a lower background reactivity and longer shelf life of the K562 panel cell lines compared with isolated neutrophils, which have been used for the cell panel to identify antibodies against HNA in human serum samples.
CONCLUSION: These results indicate that the K562 panel cell lines provide a good panel for detecting HNA-reactive neutrophil antibodies in human serum samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17319829     DOI: 10.1111/j.1537-2995.2006.01139.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Adult-onset autoimmune neutropenia with antineutrophil antibodies to an unknown neutrophil-specific antigen analyzed by using five cell-lineage immunofluorescence test and reactivity against cell lines expressing human neutrophil antigens.

Authors:  Masatoshi Nishizawa; Fumiya Hirayama; Nobuki Matsuyama; Noriko Sugino; Mitsuru Tsudo
Journal:  Int J Hematol       Date:  2010-07-22       Impact factor: 2.490

Review 2.  Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians.

Authors:  Piero Farruggia; Carlo Dufour
Journal:  Ther Adv Hematol       Date:  2015-02

3.  Establishment of a cell line panel for the detection of antibodies against human platelet antigen 4b.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Masayasu Inoue; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

4.  Evaluation of HNA-expressing cell line-based antigen capture systems and a solid-phase system for detecting HNA-1a antibodies.

Authors:  Etsuko Amakishi; Yoriko Irie; Kanae Nishizawa; Hiromi Kamada; Fumiaki Nakajima; Nobuki Matsuyama; Hiroyuki Ishii; Harumichi Matsukura; Kazuta Yasui; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2015-02-03       Impact factor: 2.490

5.  Detection of anti-human platelet antibodies against integrin α2β1 using cell lines.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Nobuki Matsuyama; Kazuta Yasui; Rika Ann Furuta; Yuji Hori; Shigenori Tanaka; Yasuo Fukumori; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2012-11-22       Impact factor: 3.443

6.  An Elderly Woman with Anti-neutrophil Antibody-positive Agranulocytosis Who Responded to High-dose Intravenous Methylprednisolone.

Authors:  Shiro Koh; Hideo Koh; Yuki Kubo; Maiko Kuroda; Mitsutaka Nishimoto; Takuro Yoshimura; Yasuhiro Nakashima; Takahiko Nakane; Hirohisa Nakamae; Masahiko Ohsawa; Masayuki Hino
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

7.  A Case of Neonatal Neutropenia Due to Anti-Fc Gamma Receptor IIIb Isoantibodies Treated with Recombinant Human Granulocyte Colony Stimulating Factor.

Authors:  Maja Tomicic; Mirta Starcevic; Vanja Zach; Jasna Bingulac-Popovic; Zeljka Hundric-Haspl
Journal:  Case Rep Med       Date:  2009-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.